Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06609317 · ClinicalTrials.gov registry record · NA

Postpartum pElvic Assisted Recovery With Leva

A NA study of Postpartum Pelvic Floor Function and Symptoms, sponsored by University of South Florida.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
2
Study locations

NCT06609317 is a NA study of Postpartum Pelvic Floor Function and Symptoms that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 25 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06609317, a NA study of Postpartum Pelvic Floor Function and Symptoms, is actively recruiting participants, sponsored by University of South Florida.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
2
Study locations

Study Summary

The goal of this prospective cohort study is to evaluate the feasibility of postpartum pelvic floor muscle training using an FDA-cleared digital therapeutic motion-based device. In addition to assessing feasibility, investigators also will evaluate bladder and bowel function, pelvic organ prolapse symptoms, and vaginal and perineal pain in the immediate postpartum period and at 3 and 6 months postpartum. Investigators also will assess sexual function at 3 and 6 months postpartum. Participants will use the motion-based device for postpartum pelvic floor muscle training and will complete electronically administered surveys at 3 and 6 months postpartum.

Interventions

  • DEVICE Digital therapeutic motion-based device

Study Locations (2)

Florida

  • University of South Florida - Tampa

Ohio

  • Ohio State University Wexner Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2025-04-04
Est. Completion 2026-02
Phase NA

Sponsor

University of South Florida

252 total trials

What the Registry Record Tells You About NCT06609317

The ClinicalTrials.gov registry entry for NCT06609317 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Postpartum Pelvic Floor Function and Symptoms appearing as the primary indexed condition, and to 1 intervention - of which Digital therapeutic motion-based device is the first listed.

NCT06609317 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Ohio.

Frequently Asked Questions

What is clinical trial NCT06609317 about?

NCT06609317 is a clinical study titled "Postpartum pElvic Assisted Recovery With Leva". The goal of this prospective cohort study is to evaluate the feasibility of postpartum pelvic floor muscle training using an FDA-cleared digital therapeutic motion-based device. In addition to assessing feasibility, investigators also will evaluate bladder and bowel function, pelvic organ prolapse ...

What is the current status of trial NCT06609317?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-04-04. Estimated completion is 2026-02.

What conditions does trial NCT06609317 study?

This clinical trial studies the following conditions: Postpartum Pelvic Floor Function and Symptoms.

What interventions are being tested in trial NCT06609317?

The interventions under investigation include: Digital therapeutic motion-based device (DEVICE).

Who is sponsoring clinical trial NCT06609317?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06609317 being conducted?

This trial has 2 study locations across Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.